3,998 Shares in Aflac Incorporated (NYSE:AFL) Acquired by Transcendent Capital Group LLC

Transcendent Capital Group LLC acquired a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,998 shares of the financial services provider's stock, valued at approximately $445,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AFL. Valued Wealth Advisors LLC boosted its position in Aflac by 24.4% during the first quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider's stock worth $55,000 after purchasing an additional 97 shares in the last quarter. Phillips Wealth Planners LLC lifted its position in shares of Aflac by 1.5% in the first quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider's stock valued at $711,000 after acquiring an additional 100 shares in the last quarter. Optas LLC lifted its position in shares of Aflac by 3.5% in the first quarter. Optas LLC now owns 2,949 shares of the financial services provider's stock valued at $328,000 after acquiring an additional 101 shares in the last quarter. Family Legacy Inc. lifted its position in shares of Aflac by 4.3% in the fourth quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock valued at $270,000 after acquiring an additional 107 shares in the last quarter. Finally, Titleist Asset Management LLC lifted its position in shares of Aflac by 3.4% in the fourth quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider's stock valued at $344,000 after acquiring an additional 110 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company's stock.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Wells Fargo & Company set a $105.00 price objective on Aflac and gave the company an "equal weight" rating in a research report on Thursday, July 10th. Morgan Stanley increased their target price on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Barclays set a $98.00 target price on Aflac and gave the stock an "underweight" rating in a research report on Monday, July 7th. Raymond James Financial reduced their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research report on Thursday, May 29th. Finally, UBS Group increased their target price on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $107.07.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the sale, the director owned 26,096 shares in the company, valued at $2,786,791.84. This trade represents a 3.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the transaction, the director directly owned 70,992 shares in the company, valued at approximately $7,496,045.28. This represents a 34.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 40,750 shares of company stock worth $4,304,295 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Aflac Stock Down 0.5%

Shares of AFL stock traded down $0.54 during trading hours on Thursday, reaching $100.90. The company had a trading volume of 505,745 shares, compared to its average volume of 2,147,842. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. Aflac Incorporated has a twelve month low of $92.44 and a twelve month high of $115.50. The company has a market capitalization of $54.55 billion, a P/E ratio of 15.75, a price-to-earnings-growth ratio of 3.11 and a beta of 0.81. The stock's fifty day simple moving average is $103.51 and its 200 day simple moving average is $105.19.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same quarter last year, the business posted $1.66 EPS. Aflac's quarterly revenue was down 37.5% compared to the same quarter last year. As a group, sell-side analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were paid a dividend of $0.58 per share. The ex-dividend date was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.30%. Aflac's dividend payout ratio (DPR) is presently 36.25%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.